Literature DB >> 11251723

Harm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.

B A Hilton1, R Thompson, L Moore-Dempsey, R G Janzen.   

Abstract

AIM: To provide a comprehensive review of the literature on harm reduction theories and strategies related primarily to licit and illicit drug use.
BACKGROUND: Although human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) disease transmission is well understood, it continues to spread, particularly among injection drug users (IDUs). Despite early indications that HIV would be contained within the IDU community, it is spreading to non-IDU sexual partners and to children of IDUs, threatening a more widespread epidemic.
METHODS: An examination of research studies and theoretical writings including reviews and policy papers published in English between 1990 and 2000.
RESULTS: Harm reduction does not seek to eliminate drug use; it focuses on minimizing the personal and social harms and costs associated with drug use and spread of HIV. It seeks to ameliorate conditions surrounding drug use responsible for the spread of HIV in the IDU community: unequal access to health services; sharing of infected needles; racial and social discrimination; poverty; exposure to street violence; inadequate housing; lack of employment; poor general or mental health and other demographic and social determinants. Some controversial harm reduction strategies are described: methadone maintenance programmes, illegal drugs dispensing under controlled conditions, needle exchanges, HIV testing, vein maintenance, safe-sex and would-care programmes.
CONCLUSION: The main challenge is to get IDUs to protect themselves against HIV when suffering physical and social privations and addiction needs. Diverse perspectives on harm reduction are problematic with consequences for success of drug use initiatives. Practical, ethical and theoretical complexities exist but further research is needed to build support for a harm-reduction orientation in practice and policy formulation.

Entities:  

Mesh:

Year:  2001        PMID: 11251723     DOI: 10.1046/j.1365-2648.2001.01672.x

Source DB:  PubMed          Journal:  J Adv Nurs        ISSN: 0309-2402            Impact factor:   3.187


  16 in total

1.  White slavery, whorehouse riots, venereal disease, and saving women: historical context of prostitution interventions and harm reduction in New York City during the Progressive Era.

Authors:  Alex Smolak
Journal:  Soc Work Public Health       Date:  2013

2.  A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders.

Authors:  Sarina R Isenberg; Allysha C Maragh-Bass; Kathleen Ridgeway; Mary C Beach; Amy R Knowlton
Journal:  J Opioid Manag       Date:  2017 Jan/Feb

3.  Exploring the Healthcare Environment and Associations with Clinical Outcomes of People Living with HIV/AIDS.

Authors:  Mary Hawk; Robert W S Coulter; James E Egan; Mackey Reuel Friedman; Steven Meanley; Stuart Fisk; Courtney Watson; Suzanne Kinsky
Journal:  AIDS Patient Care STDS       Date:  2017-11-17       Impact factor: 5.078

4.  HIV risk behaviors, perceived severity of drug use problems, and prior treatment experience in a sample of young heroin injectors in Dar es Salaam, Tanzania.

Authors:  John Atkinson; Sheryl McCurdy; Mark Williams; Jessie Mbwambo; Gad Kilonzo
Journal:  Afr J Drug Alcohol Stud       Date:  2011

5.  Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.

Authors:  Leo Beletsky; Robin Ruthazer; Grace E Macalino; Josiah D Rich; Litjen Tan; Scott Burris
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

Review 6.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

Review 7.  Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Authors:  Bluma Brenner; Mark A Wainberg; Michel Roger
Journal:  AIDS       Date:  2013-04-24       Impact factor: 4.177

8.  Risk factor profiles among intravenous drug using young adults: a latent class analysis (LCA) approach.

Authors:  Sigrid James; Edward S McField; Susanne B Montgomery
Journal:  Addict Behav       Date:  2012-09-23       Impact factor: 3.913

9.  Eliminating tobacco-related health disparities: directions for future research.

Authors:  Pebbles Fagan; Gary King; Deirdre Lawrence; Sallie Anne Petrucci; Robert G Robinson; David Banks; Sharon Marable; Rachel Grana
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

10.  Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006.

Authors:  Francois Roman; Karin Hawotte; Daniel Struck; Anne-Marie Ternes; Jean-Yves Servais; Vic Arendt; Patrick Hoffman; Robert Hemmer; Therese Staub; Carole Seguin-Devaux; Jean-Claude Schmit
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.